Details for New Drug Application (NDA): 217592
✉ Email this page to a colleague
NDA 217592 describes BALSALAZIDE DISODIUM, which is a drug marketed by Apotex Inc, Dash Pharms Natco, Hikma, Zydus Lifesciences, and Strides Pharma, and is included in five NDAs. It is available from eight suppliers. Additional details are available on the BALSALAZIDE DISODIUM profile page.
The generic ingredient in BALSALAZIDE DISODIUM is balsalazide disodium. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.
The generic ingredient in BALSALAZIDE DISODIUM is balsalazide disodium. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.
Summary for 217592
| Tradename: | BALSALAZIDE DISODIUM |
| Applicant: | Zydus Lifesciences |
| Ingredient: | balsalazide disodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217592
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 217592 | ANDA | Zydus Pharmaceuticals (USA) Inc. | 70710-1626 | 70710-1626-1 | 280 CAPSULE in 1 BOTTLE (70710-1626-1) |
| BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 217592 | ANDA | Zydus Lifesciences Limited | 70771-1841 | 70771-1841-1 | 280 CAPSULE in 1 BOTTLE (70771-1841-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 750MG | ||||
| Approval Date: | Jun 8, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
